Ascorbic acid effect on CIN incidence in diabetic patient after coronary angiography


1 Yazd Cardiovascular Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran

2 Department of Psychiatry, Iran University of Medical Sciences, Tehran, Iran


Background: This study aims to investigate the antioxidant effect of vitamin C in preventing contrast-induced nephropathy (CIN) in diabetic patients after catheterization.
Materials and Methods: In a double blinded, randomized controlled trial, 90 diabetic patients who were referred for cardiac catheterization were randomly allocated into two arms of vitamin C (A) and placebo (B). The treatment arm (A) received 2 g of vitamin C orally 2 h before catheterization and the control group (B) received 2 g of oral placebo. Six hours before catheterization, patients received fluid resuscitation with normal saline (CIN was considered as a 25% rise in creatinine (Cr) level or an increase of 0.5 mg/dL in earlier creatinine). CIN was compared between groups. Before andthree days after catheterization. Serum Bun – Cr was measured and GFR were calculated. The results were compared between the two groups. Six hours before catheterization, patients received fluid resuscitation with normal saline CIN was compare between arms.

Results: Mean GFR in group (A) before procedure was respectively 69.82±19.26 and after the treatment was 81.51±27.40 (P=0.001). But in group (B) it was 74.18±24.41 and 75.20±29.65 (P=0.747). Contrast-induced nephropathy was observed in 10 patients (12.3%) including 3 patients (7.7%) in group (A) and (16.7%, 7 patients) in group (B) (P=0.315).
Conclusion: Ascorbic acid intake in diabetic patients prior to use of contrast agents can be effective in maintaining GFR, but the incidence of contrast-induced nephropathy is not associated with the consumption of ascorbic acid.


Bartorelli Al, Marenzi G. Contrast induced nephropathy. J Interven Cardiol 2008;21:74-85.  Back to cited text no. 1
Goldenberg' I, Matetzky S. Nephropathy induced by contrast media: Pathogenesis, risk factors and preventive strategies. CMAJ 2005;172:1461-71.  Back to cited text no. 2
Mehran R, Aymong ED, Nikolsky E, Lasic Z, Iakovou I, Fahy M, et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention Development and initial validation. J Am Coll Cardiol 2004;44:1393-9.  Back to cited text no. 3
Gruberg L, Mehran R, Dangas G, Mintz GS, Waksman R, Kent KM, et al. Acute renal failure requiring hemodialysis after percutaneous coronary intervention: In-hospital and one-year outcomes. Catheter Cardiovasc Interv 2001;52:409-16.  Back to cited text no. 4
Mautone A, Brown JR. Contrast induced nephropathy in patients undergoing Elective and urgent procedures. J Interv Cardiol 2010;23:78-85.  Back to cited text no. 5
Kotzung B, Masters S, Travor A. Basic and Clinical pharmacol. Vol 2. New York: MCGraw-Hill; 2007.  Back to cited text no. 6
Martindal. The complete drug refrence. 12th ed. New York: MC Craw-Hill Medical; 2011.p. 1983-5.  Back to cited text no. 7
Brenner BM, Rector FC. The kidney.philadelphia: Saunders; 2008. p. 944.  Back to cited text no. 8
Laskey WK, Jenkins C, Selzer F, Marroguin OC, Wilensky RL, Glaser R, et al. Volume-to-creatin in clearance ratio: A pharmacokinetic ally based risk factor for prediction of early creatinine increase after percutaneous coronary intervention. J Am ColI Cardiol 2007;50:584-90.  Back to cited text no. 9
Solomon R. The role of osmolality in the incidence of contrast-induced nephropathy: A systematic review of angiographic contrast media in high risk patients. Kidney Int 2005;68:2256-63.  Back to cited text no. 10
Boscheri A, Weinbrenner C, Botzek B, Reynen K, Kuhlisch E, Strasser RH. Failure of ascorbic acid to prevent contrast- media induced nephropathy in patients with renaldys function. Clin Nephrol 2007;68:279-80.  Back to cited text no. 11
Gruberg L, Mehran R, Dangas G, Mintz GS, Waksman R, Kent KM, et al. Acute renal failure requiringdialysis after percutaneous coronary interventions. Catheterization Cardiovascul Interven 2001;52:409-16.  Back to cited text no. 12
Gami AS, Garovic VD. Contrast nephropathy after coronary angiography. Mayo Clin Proc 2004;79:211-9.  Back to cited text no. 13
Nough H, Eghbal F. Incidence of renal disfunction after angioplasty and angiography. Yazd: Shahid Sadoughi University Medical Science; 2011.  Back to cited text no. 14